Natriumchloride, Viaflo Baxter (Sodium Chloride)

Sodium chloride delivers sodium and chloride ions directly into the bloodstream. These ions increase extracellular osmolarity, drawing water into the vascular compartment, which expands blood volume and corrects low sodium concentrations. This process supports blood pressure, tissue perfusion, and cellular function across organ systems.

The dose of Natriumchloride, Viaflo Baxter is determined by the prescribing clinician based on the patient’s fluid loss, electrolyte status, weight, and clinical condition. Healthcare professionals calculate the required volume and infusion rate to safely achieve the desired fluid and sodium replacement.

Safety data for Natriumchloride, Viaflo Baxter in pregnancy and lactation are limited. Because it is a sterile saline solution, it is generally considered compatible with use when clinically indicated, but the prescriber should evaluate the risk‑benefit ratio for each individual patient.

To order Natriumchloride, Viaflo Baxter, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Natriumchloride, Viaflo Baxter is a 0.9% isotonic saline solution, providing only sodium and chloride without additional electrolytes or glucose. Compared with balanced solutions such as lactated Ringer’s, it lacks calcium, potassium, and lactate, making it suitable when those ions are contraindicated but less ideal for patients needing broader electrolyte support.

Store Natriumchloride, Viaflo Baxter at controlled room temperature, preferably below 25 °C, in its original sealed container. Protect the product from direct sunlight and moisture, and do not freeze or shake the vial before use. Follow aseptic techniques during preparation to maintain sterility.

The solution is administered intravenously by a qualified healthcare professional. It can be given as a continuous infusion or as a bolus, depending on the clinical need. The infusion rate and total volume are set by the prescriber, and the administration set should be primed to avoid air embolism.

Serious risks include fluid overload leading to pulmonary edema, severe hypernatremia causing neurological disturbances, and rare allergic reactions such as anaphylaxis. Patients with heart failure, renal impairment, or uncontrolled hypertension require close monitoring to mitigate these risks.

Contraindications include patients with known hypersensitivity to sodium chloride or any component of the formulation, and those with severe hypernatremia where further sodium administration could be harmful. Caution is also advised for individuals with uncontrolled heart failure, severe renal disease, or conditions predisposing to fluid overload.